NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

獸醫腫瘤學市的全球市場:各治療(化療,免疫療法,放射線學,及外科),動物的各類型(狗及貓),癌症的各種類的市場調查,預測(∼2025年),COVID-19的累積性的影響

Veterinary Oncology Market Research Report by Therapy, by Animal Type, by Cancer Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995286
出版日期 內容資訊 英文 182 Pages
商品交期: 最快1-2個工作天內
價格
獸醫腫瘤學市的全球市場:各治療(化療,免疫療法,放射線學,及外科),動物的各類型(狗及貓),癌症的各種類的市場調查,預測(∼2025年),COVID-19的累積性的影響 Veterinary Oncology Market Research Report by Therapy, by Animal Type, by Cancer Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 182 Pages
簡介

全球獸醫腫瘤學的市場規模,預計從2020年的5,467萬美元,至2025年末成長為7,367萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。目前進行的調查擴大了框架,以確保包括潛在的COVID-19問題和發展途徑。 本報告提供有關COVID-19的見解,其中考慮了消費者行為和需求的變化,購買方式,供應鏈的新路由,當前市場力量的動態以及政府的重要介入等COVID-19對市場的影響相關洞察。更新的調查,考慮市場上COVID-19的影響,提供洞察,分析,估計,及預測。

本報告提供獸醫腫瘤學的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,COVID-19的影響,治療、動物的種類、癌症的種類、各地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查考慮年份
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 計劃:調查計劃的作成
    • 實行:調查的實施
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場預測
  • 治療的展望
  • 癌症的種類預測
  • 動物的種類預測
  • 地區預測
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析
    • 新加入業者的威脅
    • 替代品的威脅
    • 客戶談判力
    • 供給企業談判力
    • 產業的競爭

第6章 各治療

  • 化療
  • 免疫療法
  • 放射線學
  • 手術

第7章 動物的各類型

第8章 癌症的各類型

  • 淋巴瘤
  • 乳腺癌症及鱗狀細胞癌
  • 肥胖細胞癌症

第9章 南北美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章 歐洲,中東、非洲

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獎,獎勵,擴大

第13章 企業的實用性簡介

  • Accuray Incorporated
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Karyopharm Therapeutics, Inc.,
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • One Health
  • PetCure Oncology
  • Regeneus Ltd.
  • Varian Medical System, Inc.
  • Zoetis

第14章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-A339DAEFA013

The Global Veterinary Oncology Market size was estimated at USD 57.31 Million in 2020 and expected to reach USD 62.29 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.02% to reach USD 96.23 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Veterinary Oncology to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapy , the Veterinary Oncology Market was studied across Chemotherapy, Immunotherapy, Radiology, and Surgery.

Based on Animal Type, the Veterinary Oncology Market was studied across Canine and Feline.

Based on Cancer Type, the Veterinary Oncology Market was studied across Lymphoma, Mammary and Squamous Cell Cancer, and Mast Cell Cancer.

Based on Geography, the Veterinary Oncology Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Oncology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Oncology Market, including AB Science SA, Accuray Incorporated, AdvaVet, Inc., Bayer AG, BoehringerIngelheim, Ceva Sante Animale S.A., Covetrus, Inc., Elanco, IDEXX Laboratories, Inc., Karyopharm Therapeutics, Inc.,, Morphogenesis, Inc., Nippon Zenyaku Kogyo Co., Ltd., One Health, One Health, PetCure Oncology, PetCure Oncology, LLC, PharmAust, Regeneus Ltd., Rhizen Pharmaceutical SA, Varian Medical Systems, VetDC Inc, Veterinary Cancer Group, Vetoquinol SA, Virbac SA, and Zoetis Karyopharm Therapeutics, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Veterinary Oncology Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Oncology Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Oncology Market?
  • 4. What is the competitive strategic window for opportunities in the Global Veterinary Oncology Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Veterinary Oncology Market?
  • 6. What is the market share of the leading vendors in the Global Veterinary Oncology Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Veterinary Oncology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Therapy Outlook
  • 3.4. Cancer Type Outlook
  • 3.5. Animal Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cancer in pet animals
      • 5.1.1.2. Growing R&D initiatives for cancer management
      • 5.1.1.3. Technological advancement in pet treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of pet cancer treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising awareness regarding veterinary cancer therapies
      • 5.1.3.2. Favorable government initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effect of drugs used for pet cancer treatment
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Veterinary Oncology Market, by Therapy

  • 6.1. Introduction
  • 6.2. Chemotherapy
  • 6.3. Immunotherapy
  • 6.4. Radiology
  • 6.5. Surgery

7. Veterinary Oncology Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Canine
  • 7.3. Feline

8. Veterinary Oncology Market, by Cancer Type

  • 8.1. Introduction
  • 8.2. Lymphoma
  • 8.3. Mammary and Squamous Cell Cancer
  • 8.4. Mast Cell Cancer

9. Americas Veterinary Oncology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Veterinary Oncology Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Veterinary Oncology Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AB Science SA
  • 13.2. Accuray Incorporated
  • 13.3. AdvaVet, Inc.
  • 13.4. Bayer AG
  • 13.5. BoehringerIngelheim
  • 13.6. Ceva Sante Animale S.A.
  • 13.7. Covetrus, Inc.
  • 13.8. Elanco
  • 13.9. IDEXX Laboratories, Inc.
  • 13.10. Karyopharm Therapeutics, Inc.,
  • 13.11. Morphogenesis, Inc.
  • 13.12. Nippon Zenyaku Kogyo Co., Ltd.
  • 13.13. One Health
  • 13.14. One Health
  • 13.15. PetCure Oncology
  • 13.16. PetCure Oncology, LLC
  • 13.17. PharmAust
  • 13.18. Regeneus Ltd.
  • 13.19. Rhizen Pharmaceutical SA
  • 13.20. Varian Medical Systems
  • 13.21. VetDC Inc
  • 13.22. Veterinary Cancer Group
  • 13.23. Vetoquinol SA
  • 13.24. Virbac SA
  • 13.25. Zoetis Karyopharm Therapeutics, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2020 (USD MILLION)
  • FIGURE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ONCOLOGY MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL VETERINARY ONCOLOGY MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2026
  • FIGURE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (%)
  • FIGURE 20. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2026
  • FIGURE 22. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2026
  • FIGURE 29. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 36. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 38. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. CALIFORNIA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. FLORIDA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. ILLINOIS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. NEW YORK VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. OHIO VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. PENNSYLVANIA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. TEXAS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 51. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 53. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 64. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. GLOBAL VETERINARY ONCOLOGY MARKET: FPNV POSITIONING MATRIX
  • FIGURE 76. GLOBAL VETERINARY ONCOLOGY MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 77. GLOBAL VETERINARY ONCOLOGY MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VETERINARY ONCOLOGY MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY ONCOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CALIFORNIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CALIFORNIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. FLORIDA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. FLORIDA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ILLINOIS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ILLINOIS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. NEW YORK VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. NEW YORK VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. OHIO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. OHIO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. PENNSYLVANIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PENNSYLVANIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. TEXAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. TEXAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. GLOBAL VETERINARY ONCOLOGY MARKET: SCORES
  • TABLE 122. GLOBAL VETERINARY ONCOLOGY MARKET: BUSINESS STRATEGY
  • TABLE 123. GLOBAL VETERINARY ONCOLOGY MARKET: PRODUCT SATISFACTION
  • TABLE 124. GLOBAL VETERINARY ONCOLOGY MARKET: RANKING
  • TABLE 125. GLOBAL VETERINARY ONCOLOGY MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 126. GLOBAL VETERINARY ONCOLOGY MARKET: SHARE, BY COMPANY, 2020
  • TABLE 127. GLOBAL VETERINARY ONCOLOGY MARKET: MERGER & ACQUISITION
  • TABLE 128. GLOBAL VETERINARY ONCOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 129. GLOBAL VETERINARY ONCOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 130. GLOBAL VETERINARY ONCOLOGY MARKET: INVESTMENT & FUNDING
  • TABLE 131. GLOBAL VETERINARY ONCOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 132. GLOBAL VETERINARY ONCOLOGY MARKET: LICENSE & PRICING
  • TABLE 133. GLOBAL VETERINARY ONCOLOGY MARKET: CONTACT DETAILS